S
BMRN icon

Seeyond’s BioMarin Pharmaceuticals BMRN Stock Holding History

Seeyond’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.42M Sell
33,045
-17,668
-35% -$1.66M 0.33% 92
2022
Q3 		$4.3M Buy
50,713
+1,986
+4% +$177K 0.52% 31
2022
Q2 		$4.04M Buy
48,727
+24,990
+105% +$1.99M 0.46% 35
2022
Q1 		$1.83M Sell
23,737
-5,443
-19% -$455K 0.18% 179
2021
Q4 		$2.58M Buy
29,180
+19,356
+197% +$1.6M 0.24% 114
2021
Q3 		$759K Sell
9,824
-100
-1% -$7.89K 0.07% 398
2021
Q2 		$828K Buy
9,924
+45
+0.5% +$3.57K 0.08% 381
2021
Q1 		$745K Sell
9,879
-3,717
-27% -$304K 0.07% 379
2020
Q4 		$1.19M Sell
13,596
-77
-0.6% -$6.11K 0.12% 275
2020
Q3 		$1.04M Buy
13,673
+270
+2% +$27.3K 0.11% 271
2020
Q2 		$1.65M Buy
13,403
+4,011
+43% +$399K 0.19% 156
2020
Q1 		$84K Sell
9,392
-72
-0.8% -$6.2K 0.01% 582
2019
Q4 		$800K Hold
9,464
– – 0.08% 377
2019
Q3 		$638K Buy
9,464
+3,885
+70% +$299K 0.07% 417
2019
Q2 		$478K Sell
5,579
-1,221
-18% -$104K 0.05% 454
2019
Q1 		$604K Hold
6,800
– – 0.06% 435
2018
Q4 		$579K Buy
+6,800
New +$647K 0.08% 344

Other funds holding BMRN

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Seeyond's BMRN Position: Q4 2022 in Review

Seeyond reduced its BioMarin Pharmaceuticals (BMRN) stake by 35% in Q4 2022, selling an estimated $1.66M and leaving 33,045 shares worth $3.42M. The position accounts for 0.33% of the portfolio, ranked #92.

Seeyond first reported a position in BMRN in Q4 2018 and has held it in 17 quarters since. The position peaked at $4.3M in Q3 2022. 580 funds tracked by Wall St. Rank hold BMRN as of Q4 2022.

  • Seeyond held 33,045 shares of BioMarin Pharmaceuticals worth $3.42M as of Q4 2022.
  • Seeyond sold 17,668 BioMarin Pharmaceuticals shares in Q4 2022, an estimated $1.66M.
  • BioMarin Pharmaceuticals made up 0.33% of Seeyond's portfolio in Q4 2022, its #92 holding.
  • Seeyond first reported a position in BioMarin Pharmaceuticals in Q4 2018 and has held it in 17 quarters since.
  • Seeyond's BioMarin Pharmaceuticals position peaked at $4.3M in Q3 2022.
  • 580 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2022.

Based on Seeyond's 13F filing for Q4 2022, filed 13 Feb 2023.